Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...

Novo Nordisk faces slowing demand, rising competition, and CEO transition. Learn about challenges impacting its growth and ...

Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $6.87. The announcement from United Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

Corporate Counsel, in partnership with ALM Intelligence, on Monday released its 2025 General Counsel Report, an exclusive ...

While most commercial office landlords are still hunting for post‑pandemic tenants, there's a sector of the real estate industry that's breeding breakout growth: life sciences. Global biotech spending ...

You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on 11/01/2006. An increasingly popular option among retail and ...

The S&P 500 and the Nasdaq Composite ended Thursday's session with fresh record closes after scoring new all-time intraday ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

TORONTO, ON / ACCESS Newswire / July 29, 2025 / Highlander Silver Corp. (TSX:HSLV) (“Highlander Silver” or the “Company“) is ...